DAM
Derbend Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $250K | Sell |
3,673
-80
| -2% | -$5.45K | 0.12% | 102 |
|
|
2023
Q4 | $235K | Buy |
+3,753
| New | +$235K | 0.14% | 95 |
|
|
2023
Q3 | – | Sell |
-4,175
| Closed | -$234K | – | 98 |
|
|
2023
Q2 | $234K | Buy |
+4,175
| New | +$234K | 0.16% | 70 |
|
|
2022
Q4 | – | Sell |
-4,585
| Closed | -$300K | – | 78 |
|
|
2022
Q3 | $300K | Sell |
4,585
-82
| -2% | -$5.37K | 0.24% | 59 |
|
|
2022
Q2 | $284K | Sell |
4,667
-7,047
| -60% | -$429K | 0.24% | 56 |
|
|
2022
Q1 | $888K | Hold |
11,714
| – | – | 0.87% | 39 |
|
|
2021
Q4 | $888K | Sell |
11,714
-2,249
| -16% | -$170K | 0.87% | 39 |
|
|
2021
Q3 | $1.56M | Buy |
13,963
+1,465
| +12% | +$164K | 1.47% | 18 |
|
|
2021
Q2 | $2.02M | Buy |
+12,498
| New | +$2.02M | 1.88% | 15 |
|